How bacteria resist ‘last-resort’ antibiotic

The way in which a gene protects bacteria from a “last resort” antibiotic that treats life-threatening infections has been revealed for the first time in a global research project.

The findings of the international research team, led by the University of Bristol, UK, have been hailed as vital in the understanding of colistin resistance.

The results follow research published last year in which a team from the University’s School of Cellular and Molecular Medicine, working with colleagues from Oxford, Cardiff, Diamond Light Source, Thailand and China, identified mcr-1 as the first colistin-resistance gene that could be passed between bacteria.

This latest discovery, which is published in Scientific Reports, examines how the mcr-1 gene protects bacteria from colistin, an antibiotic used to treat life-threatening bacterial infections that do not respond to other treatment options.

Study co-author Professor Adrian Mulholland, of the School of Chemistry, said: "The importance of understanding colistin resistance can hardly be overstated: it is rapidly emerging threat to public health.”

The mcr-1 gene has been detected in common bacteria, such as E. coli, in China, USA and Europe first in farm animals and more recently in human patients.

Colistin acts by binding to, and disrupting, the outer surface of bacteria. Any bacteria carrying the mcr-1 gene makes a protein that alters its surface to reduce colistin binding, which causes the resistance.

The research team used X-rays to generate detailed pictures of the part of the protein that makes the change to the surface and identified its key features. They also constructed computer models of the chemical reaction that leads to resistance.

Professor Mulholland said the work also provides researchers with information that could help them to identify ways of blocking MCR-1 function, which would enable colistin activity to begin once more against bacteria-carrying mcr-1.

“Our results illuminate the structural and (for the first time) mechanistic basis of transferable colistin resistance conferred by mcr-1, thanks to the combination of biological, chemical and computational expertise brought to bear on this project,” he said.

“We are confident that our findings will drive efforts to understand mcr-1-mediated resistance and ultimately help identify routes towards overcoming MCR-1 activity in harmful bacteria.”

Hinchcliffe P, Mulholland A, Spencer J et al. Insights into the Mechanistic Basis of Plasmid-Mediated Colistin Resistance from the Crystal Structure of the Catalytic Domain of MCR-1. Scientific Reports 7 January, 2017; doi:10.1038/srep39392

, ,

Leave a Reply

Your email address will not be published. Required fields are marked *

Search

Categories

Monthly Posts

Our Clients

BSH
Practice Index